Tang Kevin

Tang Kevin is listed in filings as Chief Executive Officer at Aurinia Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Jun 2, 2026, including purchase activity. Recent filings connect the profile to Aurinia Pharmaceuticals Inc. (AUPH) and Singular Genomics Systems, Inc. (OMIC). The current snapshot covers public activity from Sep 18, 2024 to Jun 2, 2026. Reported amounts are shown as $3.1M to $5.2M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.